1 of 1
SENATE DOCKET, NO. 1765 FILED ON: 1/19/2023
SENATE . . . . . . . . . . . . . . No. 1384
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
John F. Keenan
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to the prescription monitoring program.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :John F. KeenanNorfolk and Plymouth 1 of 2
SENATE DOCKET, NO. 1765 FILED ON: 1/19/2023
SENATE . . . . . . . . . . . . . . No. 1384
By Mr. Keenan, a petition (accompanied by bill, Senate, No. 1384) of John F. Keenan for
legislation relative to the prescription monitoring program. Public Health.
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 1451 OF 2021-2022.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act relative to the prescription monitoring program.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Section 24A of Chapter 94C of the General Laws, as appearing in the 2020
2Official Edition, is hereby amended by inserting after subsection (c) the following new
3subsection:-
4 (c½) The department shall establish, by rule or regulation, a process by which to include
5information about the administration of opioid maintenance treatment in the prescription
6monitoring program, when the inclusion of such information does not conflict with state or
7federal privacy rules. The purpose of this subsection shall be to ensure that licensed professionals
8authorized to prescribe controlled substances receive information, through utilization of the
9prescription monitoring program, about an individual patient’s participation in opioid 2 of 2
10maintenance treatment prior to issuing a new prescription for an opioid substance other than the
11substance used for opioid maintenance treatment.
12 SECTION 2. Section 18 of chapter 111E of the General Laws, is hereby amended by
13inserting after subsection (a) the following new subsection:-
14 (a½) For each facility that is an opioid treatment program, as defined under 42 CFR Part
158, the facility shall present to each individual entering treatment a form that allows the individual
16to consent to the release of information, through the prescription monitoring program, about the
17administration of opioid maintenance treatment at the facility. Said consent form shall be
18accompanied by information clearly explaining that such consent is not required but is
19encouraged to improve coordination of services; and by information on how the individual may
20complete and return the form to the facility or to the department of public health if they elect to
21give such consent. A record of the individual’s election relative to this form shall be maintained
22by the facility as part of the record of treatment required by this section. The same form and
23information shall be presented to the individual upon their discharge from the facility.